Ecolab Inc. – Consensus Indicates Potential 8.5% Upside
Ecolab Inc. with ticker code (ECL) now have 18 analysts in total covering the stock. The consensus rating is ''Hold''. The range between the high target price and low target price is between 198 and 163 and has a mean target at 179.33. Given that the stocks previous close was at 165.26 this now indicates there is a potential upside of 8.5%. The 50 day moving average now sits at 162.19 and the 200 moving average now moves to 183.54. The market capitalisation for the company is $47,003m. You can visit the company''s website by visiting: https:||www.ecolab.com [stock_market_widget type="chart" template="basic" color="green" assets="ECL" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $51,005m based on the market concensus. Ecolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally. The company operates through Global Industrial, Global Institutional Specialty, and Global Healthcare Life Sciences segments.
Ecolab Inc. – Consensus Indicates Potential 8.5% Upside
Ecolab Inc. with ticker code (ECL) now have 18 analysts in total covering the stock. The consensus rating is ''Hold''. The range between the high target price and low target price is between 198 and 163 and has a mean target at 179.33. Given that the stocks previous close was at 165.26 this now indicates there is a potential upside of 8.5%. The 50 day moving average now sits at 162.19 and the 200 moving average now moves to 183.54. The market capitalisation for the company is $47,003m. You can visit the company''s website by visiting: https:||www.ecolab.com [stock_market_widget type="chart" template="basic" color="green" assets="ECL" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $51,005m based on the market concensus. Ecolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally. The company operates through Global Industrial, Global Institutional Specialty, and Global Healthcare Life Sciences segments.